Skip to main content
. 2015 Jul 7;23(9):1486–1496. doi: 10.1038/mt.2015.108

Figure 4.

Figure 4

Circulating tumor cell (CTC) identification in clinical blood samples. (a) Blood sample preparation. Red blood cells were lysed with hypotonic NH4Cl solution followed by incubation with hypotonic NaCl. (b) Costaining of CTCs from blood of a patient with lung adenocarcinoma by a Cy-5-labeled LC-18 aptamer and FITC-labeled anti-pan cytokeratin antibodies. (c) Costaining of CTCs from blood of a patient with squamous lung cancer by Cy-5-labeled LC-18 aptamer and FITC-labeled anti-pan cytokeratin antibodies. (d) Costaining of CTCs from blood of a colon cancer patient with lung metastases by Cy-5-labeled LC-18 aptamer and FITC-labeled anti-pan cytokeratin antibodies. Magnification ×60.